Compare · EHAB vs HIMS
EHAB vs HIMS
Side-by-side comparison of Enhabit Inc. (EHAB) and Hims & Hers Health Inc. (HIMS): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both EHAB and HIMS operate in Medical/Nursing Services (Health Care), so they compete in similar markets.
- HIMS is the larger of the two at $6.85B, about 9.7x EHAB ($706.9M).
- Over the past year, EHAB is up 71.4% and HIMS is down 43.6% - EHAB leads by 115.1 points.
- HIMS has hit the wire 10 times in the past 4 weeks while EHAB has been quiet.
- HIMS has more recent analyst coverage (25 ratings vs 19 for EHAB).
- Company
- Enhabit Inc.
- Hims & Hers Health Inc.
- Price
- $13.80+0.00%
- $28.05-4.54%
- Market cap
- $706.9M
- $6.85B
- 1M return
- +0.69%
- +0.70%
- 1Y return
- +71.43%
- -43.64%
- Industry
- Medical/Nursing Services
- Medical/Nursing Services
- Exchange
- NYSE
- NYSE
- IPO
- 2022
- 2019
- News (4w)
- 0
- 10
- Recent ratings
- 19
- 25
Enhabit Inc.
Enhabit, Inc. provides home health and hospice services in the United States. Its home health services include patient education, pain management, wound care and dressing changes, cardiac rehabilitation, infusion therapy, pharmaceutical administration, and skilled observation and assessment services; practices to treat chronic diseases and conditions, including diabetes, hypertension, arthritis, Alzheimer's disease, low vision, spinal stenosis, Parkinson's disease, osteoporosis, complex wound care and chronic pain, along with disease-specific plans for patients with diabetes, congestive heart failure, post-orthopedic surgery, or injury and respiratory diseases; and physical, occupational and speech therapists provide therapy services. The company also offers hospice services, including pain and symptom management, palliative and dietary counseling, social worker visits, spiritual counseling, and bereavement counseling services to meet the individual physical, emotional, spiritual, and psychosocial needs of terminally ill patients and their families. As of March 31, 2022, it operated in 252 home health agencies and 99 hospice agencies across 34 states. The company was formerly known as Encompass Health Home Health Holdings, Inc. and changed its name to Enhabit, Inc. in March 2022. Enhabit, Inc. was incorporated in 2014 and is headquartered in Dallas, Texas. As of July 1, 2022, Enhabit, Inc. operates as a standalone company.
Hims & Hers Health Inc.
Hims & Hers Health, Inc. operates a multi-specialty telehealth platform that connects consumers to licensed healthcare professionals. The company offers a range of health and wellness products and services available for purchase on its websites directly by customers. It provides prescription medication on a recurring basis and ongoing care from healthcare providers; and over-the-counter drug and device products, as well as cosmetics and supplement products, primarily focusing on wellness, sexual health, skincare, and hair care. The company's curated non-prescription products include vitamin C, melatonin, collagen protein, biotin, and teas in the wellness category; moisturizer, fragrances, face wash, and anti-wrinkle creams in the skincare category; condoms and lubricants in the sexual health category; and shampoos, conditioners, scalp scrubs, and topical treatments, such as minoxidil in the hair care category. It also offers medical consultation services; and engages in the wholesale of non-prescription product sales to retailers. Hims & Hers Health, Inc. is based in San Francisco, California.
Latest EHAB
- Amendment: SEC Form SCHEDULE 13G/A filed by Enhabit Inc.
- SEC Form 15-12G filed by Enhabit Inc.
- SEC Form S-8 POS filed by Enhabit Inc.
- SEC Form S-8 POS filed by Enhabit Inc.
- President and CEO Jacobsmeyer Barbara Ann returned $16,704,541 worth of shares to the company (1,210,474 units at $13.80) and was granted 603,767 shares, closing all direct ownership in the company (SEC Form 4)
- General Counsel and Secretary Black Dylan C returned $2,869,144 worth of shares to the company (207,909 units at $13.80) and was granted 108,086 shares, closing all direct ownership in the company (SEC Form 4)
- EVP of Home Health Operations Jolley Julie Diane returned $3,678,238 worth of shares to the company (266,539 units at $13.80) and was granted 129,409 shares, closing all direct ownership in the company (SEC Form 4)
- Chief Human Resources Officer Marion Tanya Renee returned $2,904,031 worth of shares to the company (210,437 units at $13.80) and was granted 103,674 shares, closing all direct ownership in the company (SEC Form 4)
- EVP of Hospice Operations Kalvaitis Jeanne Louise returned $1,593,900 worth of shares to the company (115,500 units at $13.80) and was granted 53,625 shares, closing all direct ownership in the company (SEC Form 4)
- SEC Form 4 filed by Enhabit Inc.
Latest HIMS
- SEC Form 4 filed by Hims & Hers Health Inc.
- SEC Form 3 filed by Hims & Hers Health Inc.
- Hims & Hers to Announce Third Quarter 2026 Financial Results on November 9, 2026
- Hers Launches in Australia, Built to Care for the Whole Woman
- SEC Form 8-K filed by Hims & Hers Health Inc.
- Hims & Hers Names Jon Franklin as Chief Accounting Officer
- Chief Financial Officer Okupe Oluyemi sold $59,400 worth of shares (2,000 units at $29.70) as part of a pre-agreed trading plan, decreasing direct ownership by 0.85% to 234,527 units (SEC Form 4)
- Chief Legal Officer Boughton Soleil sold $100,957 worth of shares (3,461 units at $29.17) as part of a pre-agreed trading plan, decreasing direct ownership by 1% to 300,809 units (SEC Form 4)
- Hims & Hers Names Chief Medical Officers in the UK and Australia, Deepening its Investment in Local Clinical Leadership
- Chief Financial Officer Okupe Oluyemi sold $876,846 worth of shares (29,277 units at $29.95) as part of a pre-agreed trading plan and exercised 14,000 shares at a strike of $5.01, decreasing direct ownership by 6% to 236,527 units (SEC Form 4)